Tyra Biosciences annual operating expenses
2020
2021
2022
2023
2024
2025
Tyra Biosciences Operating Expenses Growth & History (TYRA)
Tyra Biosciences's operating expenses was $132.8M for fiscal 2025.
View full Tyra Biosciences company overviewTyra Biosciences annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $132.8M | $28.6M | +27.44% |
| 2024 | 2024-12-31 | $104.2M | $24.2M | +30.31% |
| 2023 | 2023-12-31 | $79.9M | $21.0M | +35.67% |
| 2022 | 2022-12-31 | $58.9M | $32.6M | +124.16% |
| 2021 | 2021-12-31 | $26.3M | $17.0M | +182.76% |
| 2020 | 2020-12-31 | $9.3M | — | — |
Tyra Biosciences quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $49.0M | $17.6M | +55.80% |
| Q1 2026 | 2026-03-31 | $42.0M | $10.1M | +31.86% |
| Q4 2025 | 2025-12-31 | $36.5M | $6.8M | +22.87% |
| Q3 2025 | 2025-09-30 | $32.9M | $4.3M | +15.17% |
| Q2 2025 | 2025-06-30 | $31.5M | $7.9M | +33.66% |
| Q1 2025 | 2025-03-31 | $31.9M | $9.5M | +42.68% |
| Q4 2024 | 2024-12-31 | $29.7M | $4.1M | +15.94% |
| Q3 2024 | 2024-09-30 | $28.6M | $4.6M | +19.37% |
| Q2 2024 | 2024-06-30 | $23.5M | $7.5M | +46.95% |
| Q1 2024 | 2024-03-31 | $22.3M | $8.0M | +55.73% |
| Q4 2023 | 2023-12-31 | $25.6M | $10.6M | +70.67% |
| Q3 2023 | 2023-09-30 | $24.0M | $10.3M | +75.62% |
| Q2 2023 | 2023-06-30 | $16.0M | $586,000 | +3.80% |
| Q1 2023 | 2023-03-31 | $14.3M | −$500,000 | −3.37% |
| Q4 2022 | 2022-12-31 | $15.0M | $5.1M | +51.24% |
| Q3 2022 | 2022-09-30 | $13.6M | $7.0M | +105.56% |
| Q2 2022 | 2022-06-30 | $15.4M | $9.9M | +180.10% |
| Q1 2022 | 2022-03-31 | $14.8M | $10.6M | +252.27% |
| Q4 2021 | 2021-12-31 | $9.9M | — | — |
| Q3 2021 | 2021-09-30 | $6.6M | $4.3M | +184.65% |
| Q2 2021 | 2021-06-30 | $5.5M | — | — |
| Q1 2021 | 2021-03-31 | $4.2M | — | — |
| Q3 2020 | 2020-09-30 | $2.3M | — | — |
Tyra Biosciences operating expenses trends
Over the last five fiscal years, Tyra Biosciences's operating expenses increased from $9.3M to $132.8M, a change of $123.5M. The latest reported quarter, Q2 2026, shows $49.0M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tyra Biosciences source filings ↗